ReviewFrontiers in cell and developmental biology2026
The AI-Augmented Ophthalmologist for chronic ocular diseases: a patient-centered framework for human-AI collaboration.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence is increasingly positioned as a means of addressing the growing burden of ophthalmic disease, particularly in settings where specialist resources are scarce and visual impairment remains preventable. Yet much of ophthalmic AI has remained confined to algorithmic validation, with limited translation into routine care because of persistent barriers in trust, interoperability, accountability, and clinical fit. This article proposes the AI-Augmented Ophthalmologist as a conceptual and practical framework for human-AI collaboration in eye care. Rather than treating AI as a replacement for clinical expertise or as a standalone diagnostic tool, the framework defines three complementary forms of augmentation: perceptual augmentation, which extends the clinician's capacity to interpret high-dimensional multimodal data; decisional augmentation, which supports risk prediction, treatment planning, surgical safety, and personalized management; and empathetic augmentation, which redistributes clinical capacity toward communication, shared decision-making, and patient engagement. By synthesizing evidence from clinical studies, implementation research, and emerging foundation-model applications, this review shows how AI can restructure fragmented ophthalmic workflows into a continuous, patient-centered loop spanning screening, diagnosis, treatment, and follow-up. The conceptual innovation of this framework lies in shifting ophthalmic AI from task-level automation to system-level collaboration, in which technical precision, clinical judgment, and humanistic care are integrated rather than separated. We further outline the conditions needed to move ophthalmic AI from algorithmic validation to real-world clinical integration: context-aware explainability, human-centered workflow design, adaptive regulation, continuous performance auditing, and equity-oriented deployment. The AI-Augmented Ophthalmologist offers a roadmap for moving ophthalmic AI beyond the digital showcase toward sustainable, trustworthy, and equitable clinical integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.